Although arterial stiffness is an independent cardiovascular risk factor associated with both aging and hypertension, relatively little is known regarding the structural changes in the vessel wall that occur with vessel stiffening. We determined if collagen type-I metabolism is related to arterial stiffening in both hypertensive and normotensive subjects. Arterial stiffness was assessed by aortic pulse wave velocity (PWV) and augmentation index (AIx) in 46 subjects (48.772 years, 32 hypertensives) and related to circulating markers of collagen type-I turnover. Collagen synthesis was assessed by the measurement of carboxy-terminal peptide of procollagen type-I (PIP) and collagen degradation by the measurement of carboxy-terminal telopeptide of collagen type-I (ICTP), by quantitative immunoassay. Matrix metalloproteinase-1 (MMP-1) and the tissue inhibitor of metalloproteinase-1 (TIMP-1) were also quantified by immunoassay. The ratio of collagen type-I synthesis to degradation was negatively correlated with both PWV (Po0.05) and AIx (Po0.05), whereas plasma MMP-1 levels displayed a positive correlation with both PWV (Po0.01) and AIx (Po0.01), after adjustment for age and mean arterial pressure. The relationship between collagen type-I turnover and arterial stiffness was similar in both the normotensive and hypertensive subjects. Although circulating markers of collagen synthesis were increased in the hypertensive subjects, this was not related to arterial stiffness. Collagen type-I degradation is increased in relation to collagen type-I synthesis in subjects with stiffer arteries. Matrix metalloproteinase-1, the enzyme responsible for collagen type-I degradation, is positively related to both large elastic and muscular artery stiffness in normotensive and hypertensive subjects.
Introduction
Arterial stiffness is well established as an independent marker of cardiovascular risk in hypertension and is of greater prognostic importance than simple measures of blood pressure (BP). Stiffening of large central arteries, particularly the aorta, occurs during physiological processes such as aging, 1, 2 and also during pathological processes such as hypertension, 3 diabetes mellitus 4 and end-stage renal disease. 5 In addition, chronic alcohol consumption and cigarette smoking also stiffen arteries. 6, 7 Large artery stiffness leads to an increase in systolic BP, a reduction in diastolic BP and an increase in pulse pressure (PP). This may result in increased myocardial oxygen demand, ventricular after-load and decreased coronary perfusion.
Increased large artery stiffness, measured as pulse wave velocity (PWV), is the velocity of the pulse wave between two sites of the respective arterial segment, and is a widely accepted technique in the evaluation of arterial stiffness. 8 Aortic PWV has been shown to be a strong independent predictor of cardiovascular and all-cause mortality in patients with diabetes and end-stage renal disease. 9, 10 Higher PWV in hypertensive patients is also associated with cardiovascular morbidity and mortality. 11 Increased PWV leads to an early return of reflected waves from the periphery to the ascending aorta, and thus generating a late aortic systolic peak, which is a measure of systolic augmentation in the aorta and expressed as the augmentation index (AIx). The AIx is a global estimate of arterial stiffness and depends upon PWV and the magnitude of reflected waves from the periphery and pattern of left ventricular ejection. The early or systolic reflected waves have detrimental consequences for ventricular-vascular interaction; the heart faces increased left ventricular after-load and also looses the diastolic boost to coronary perfusion pressure.
Thus, AIx has been shown to be an independent prognosticator for all-cause and cardiovascular mortality in patients with end-stage renal disease, 12 and more recent data show it to be a significant predictor of coronary artery disease in men under the age of 60 years. 13 There are extensive data in the literature describing the effect of physiological and pharmacological modulations of PWV and AIx. However, there are relatively scant data on the role of structural alterations in the vessel wall that mediate changes in arterial stiffness.
The peripheral vasculature undergoes extensive remodelling in the hypertensive state and also during aging in the absence of cardiovascular disease. Fibrous tissue accumulation is an important feature of this process due to excess total collagen formation, decreased degradation or both. However, collagen is composed of distinct subtypes, which show considerable diversity in their structure and function. A change in the proportions of collagen subtypes may therefore markedly affect the mechanical properties of the vessel wall. The predominant collagen subtypes found in the normal human arterial wall are type-I (70-75%) and type-III (20-25%), with type-V comprising 1-2%.
14 Although there is disagreement regarding absolute collagen accumulation in vessel stiffening, it has been shown that alterations in the composition of the collagen subtypes occur in hypertensive rats with stiffer arteries. 15, 16 The regulation of extracellular matrix turnover and collagen metabolism is related to matrix metalloproteinase (MMP) activity. Matrix metalloproteinases and their tissue inhibitors, tissue inhibitor of metalloproteinase-1 (TIMPs), may play an important role in the modulation of the extracellular matrix and thus arterial stiffness. The ratelimiting step in the extracellular degradation of collagen type-I is the cleavage by MMP-1, accounting for the degradation of 40% of newly synthesized collagen type-I in different tissues, and its activity in turn depends upon the concentration of its tissue inhibitor (TIMP-1).
As stiffening of both the large elastic arteries, aortic PWV and smaller muscular arteries, as reflected by AIx, progresses with both aging and hypertension, and alterations in collagen subtypes may be related to stiffer arteries, we hypothesized that collagen type-I turnover and arterial stiffness are related in essential hypertension. Therefore, we measured the plasma concentrations of peptide of procollagen type-I (PIP) (collagen production), ICTP (collagen degradation), PIP:ICTP ratio, which reflects collagen turnover in the arterial wall; we also measured plasma levels of MMP-1, the major degrader of collagen type-1 and TIMP-1, the tissue inhibitor of MMP-1 and related these plasma markers to arterial stiffness in hypertensive patients and age-matched normotensive subjects.
Materials and methods

Study population
The study population consisted of a group of nevertreated patients (n ¼ 46, 48.772 years, 22 female; Abbreviations: AIx, augmentation index; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MAP, mean arterial pressure; PP, pulse pressure; PWV, pulse wave velocity.
Arterial stiffness and collagen type-I degradation M McNulty et al bone and collagen turnover. Left ventricular hypertrophy (LVH) was diagnosed on the basis of standard 12-lead electrocardiogram (ECG). The subjects were studied fasting, having abstained from caffeine, alcohol and smoking in the previous 12 h. Baseline haemodynamic measurements were recorded in each subject after a supine rest for 15 min in a quiet room at 221C. The subjects gave informed consent, and the study had institutional ethics committee permission.
BP measurements
Brachial BP and heart rate were measured with an automated digital oscillometric monitor (Omron model HEM 705-CP, Omron Healthcare Inc., Vernon Hills, IL, USA), and a mean of three readings was taken. Brachial PP was calculated as the difference between systolic and diastolic BP.
Measurement of PWV
Carotid-femoral PWV was determined with the footto-foot method (Complior, Colson, Dupont Medical, Paris, France) as described previously. 17 Briefly, the simultaneous recordings by two pressure-sensitive transducers of the carotid and femoral artery waveforms and measurement of the time delay of successive records from the foot of each wave, divided by the distance between the transducers measured over the body surface, allow calculation of PWV in metres/second (m/s).
Derivation of the aortic pressure waveform
The technique of pulse wave analysis was used. A high-fidelity micromanometer (SPC-301, Millar Instruments) was used to flatten the radial artery, and the radial pulse was continuously recorded. The aortic pressure waveform was derived from radial tonometry using a previously validated transfer function, relating radial to aortic pressure waveform within the system software (SphygmoCor, AtCor Medical, version 7.0), as described previously, 18 and ascending aortic pressures and the AIx were derived from the aortic pressure waveform.
Measurement of PIP, ICTP, MMP-1 and TIMP-1
Fasting blood samples were collected in the presence of heparin or ethylene diamine tetraacetic acid. Samples were centrifuged at 2500 g for 10 min at 41C, and plasma collected and stored at À801C until analysis. Commercially available immunoassays were used to measure plasma levels of PIP (Takara Bio Inc., Shiga, Japan), ICTP (Orion Diagnostica, Espoo, Finland), total MMP-1 free and bound to TIMP-1 (Amersham Biosciences, Quebec, Canada) and TIMP-1 (Chemicon, Temecula, CA, USA) according to the manufacturer's instructions.
In addition, the plasma levels of total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, glucose and creatinine were measured by standard methods.
Statistical analysis
Data were analysed with JMP (JMP IN, version 5.0, SAS Institute Inc.). Where data were not distributed normally, non-parametric methods (Wilcoxon Rank Sums Test) were used. Correlations between the haemodynamic parameters and plasma makers were derived using multivariate correlations (Spearman's r). As both the markers of collagen turnover and arterial stiffness are strongly related to age and BP, we looked at the relationship between these parameters using stepwise regression model. In the first model, we used PWV as the dependent variable and AIx was the dependent variable in the second model. All the results are expressed as mean7s.e.m. and Po0.05 was considered significant.
Results
The clinical characteristics of the patient population are given in Table 1 . The patients were matched for age, body mass index and smoking status. There was a nonsignificant trend for a greater number of female subjects in the normotensive group (Table 1) . The BP and PWV were significantly higher in the hypertensive group with similar AIx and heart rate in the two populations ( Table 1 ). The total cholesterol levels were higher in the hypertensive group, although this was not statistically significant. However, LDL cholesterol, plasma glucose, triglycerides, HDL cholesterol and serum creatinine were similar in the two groups. One hypertensive patient had ECG evidence of LVH.
Relationship between collagen turnover and PWV The PIP:ICTP ratio (a measure of collagen type-I turnover synthesis/degradation) although unrelated to age or BP displayed a significant relationship with PWV (r ¼ À0.36; Po0.05; Figure 1 ). When the Figure 1 The relationship between pulse wave velocity (m/s) and PIP:ICTP ratio in hypertensive and normotensive subjects.
Arterial stiffness and collagen type-I degradation M McNulty et al relationship was examined separately in the hypertensive and normotensive groups, the relationship between PIP:ICTP ratio and PWV was weaker in the normotensive group and did not reach statistical significance (r ¼ À0.36; P ¼ 0.2), in comparison with the hypertensive group (r ¼ À0.42; Po0.05). The PIP:ICTP ratio was inversely related to plasma LDL levels (r ¼ À0.30, Po0.05). In a stepwise regression model, age, PIP:ICTP ratio and LDL were the independent predictors of PWV (R 2 ¼ 0.60, Po0.0001). Plasma PIP (marker of collagen type-I synthesis) levels were not related to PWV or the lipid and glucose levels, whereas plasma ICTP levels (marker of collagen type-I degradation) displayed a positive correlation with PWV (r ¼ 0.51; Po0.001; Figure 2 ), which remained significant after adjustment for age and mean arterial pressure (MAP) (Po0.01) and an inverse relationship with HDL cholesterol (r ¼ À0.38, Po0.05). This relationship was not present when the groups were divided into hypertensives and normotensives.
Plasma MMP-1 levels displayed a positive relationship with PWV (r ¼ 0.50; Po0.001; Figure 3 ), which remained significant after adjustment for age and MAP (Po0.01). This relationship was also similar when both normotensive and hypertensive subjects were analysed individually. There was no significant relationship between MMP-1 levels and either plasma glucose or lipids. In a stepwise regression model with PWV as the dependent variable, only age, MMP-1 and plasma LDL independently predicted PWV (R 2 ¼ 57, Po0.0001). Plasma MMP-1 levels also displayed a positive correlation with ICTP (r ¼ 0.38; Po0.05).
There was a weak negative relationship with the TIMP-1/MMP-1 ratio and PWV (r ¼ À0.29; Po0.05), although TIMP-1 levels were not related to PWV. There was however an inverse relationship between plasma triglycerides and TIMP-1 levels (r ¼ À0.41, Po0.01) and TIMP-1/MMP-1 ratio (r ¼ À0.30, Po0.05) and a positive association of HDL cholesterol with TIMP-1 (r ¼ 0.29, Po0.05).
Relationship between collagen turnover, aortic pressures and arterial wave reflection The PIP:ICTP ratio also displayed a significant negative relationship with AIx (r ¼ À0.29; Po0.05). This relationship between PIP:ICTP and AIx was not present when the hypertensives and normotensives were analysed as separate groups. In a stepwise regression model, gender, heart rate, MAP and PIP:ICTP ratio were the independent predictors of AIx (R 2 ¼ 0.55, Po0.0001). As for PWV, plasma ICTP levels displayed a positive correlation with AIx (r ¼ 0.35; Po0.05) and the relationship was not present when the groups were divided into hypertensive and normotensive subjects.
Plasma MMP-1 levels displayed a positive relationship with AIx (r ¼ 0.51; Po0.001), which remained significant after adjustment for age and MAP (Po0.01). This relationship was also similar when both normotensive and hypertensive subjects were analysed with AIx individually. In a stepwise regression model with AIx as the dependent variable, only age, MMP-1 and LDL cholesterol independently predicted AIx (R 2 ¼ 56, Po0.0001). The TIMP-1/MMP-1 displayed a negative correlation with AIx (r ¼ À0.42; Po0.05), which remained when the groups were analysed as hypertensives and normotensives. As for PWV, TIMP-1 levels were not related to AIx.
Comparison of plasma markers of collagen turnover in hypertensive and normotensive subjects Plasma PIP levels (collagen type-I synthesis) were significantly higher in the hypertensive group versus the normotensive group (839750 versus 648757 ng/ml, Po0.05), whereas plasma ICTP levels (collagen type-I degradation) were similar in both groups (4.270.4 versus 4.870.2 ng/ml). There was no statistical difference in the plasma MMP-1 levels between the hypertensive and normotensive subjects (12.771 versus 10.871 ng/ml). Tissue inhibitor of metalloproteinase-1 levels were similar Figure 2 The relationship between pulse wave velocity (m/s) and plasma telopeptide of collagen type-I (ICTP) levels (ng/ml) in hypertensive and normotensive subjects. Figure 3 The relationship between pulse wave velocity (m/s) and plasma matrix metalloproteinase-1 levels (ng/ml) in hypertensive and normotensive subjects.
Arterial stiffness and collagen type-I degradation M McNulty et al in the hypertensive (9377 ng/ml) and normotensive groups (9276 ng/ml), as was the TIMP-1/MMP-1 ratio (971.2 versus 870.7).
Discussion
As one of the main underlying mechanisms of arterial stiffness is arterial fibrosis, most studies have focused on absolute collagen content and concentration, the results of which are conflicting. 15, [19] [20] [21] However, the aorta is comprised of distinct collagen subtypes, the majority of which is made up by collagen type-I, with smaller contributions from types III and V. Alterations in the proportions of arterial collagen types may affect vascular stiffness, regardless of changes in the absolute collagen content. It is well established that extracellular matrix-degrading enzymes play an important role in tissue remodelling, although it is not clear if these enzymes affect large artery stiffness through the alteration of collagen metabolism.
We found ICTP levels to be similar in both normotensive and hypertensive subjects despite higher levels of PIP in the hypertensive group, confirming other studies. 22 ,23 Yet, despite increased circulating markers of collagen type-I synthesis (PIP) in the hypertensive subjects, we did not see any relationship with PIP and arterial stiffness.
However, the ratio of collagen type-I synthesis in relation to collagen type-I degradation (PIP:ICTP) displayed a negative correlation with arterial stiffness. Although PIP:ICTP displayed a similar relationship with PWV in normotensives as in hypertensives, this did not reach statistical significance, which may be explained by the smaller group size. Therefore, in both hypertensive and normotensive subjects with stiffer arteries, collagen type-I turnover is altered, either owing to reduced collagen type-I synthesis or increased collagen type-I degradation. As our results show that ICTP levels (marker of collagen type-I degradation) increase with increasing PWV as do MMP-1 levels (responsible for the degradation of native collagen type-I), increased collagen type-I degradation is likely to be responsible for the reduced PIP:ICTP ratio in subjects with stiffer arteries. The relationship between markers of collagen type-I turnover displays similar relationships with both PWV and AIx, although the relationship with both PIP:ICTP and ICTP is stronger for PWV than for AIx. This may suggest that collagen turnover is more important in determining PWV, a marker of aortic stiffness, than AIx, which is largely determined by wave reflections and represents much more the vasomotor tone in the small medium-sized muscular vessels downstream in the circulation.
However, both PWV and AIx are significantly related to increased plasma MMP-1 levels reflective of increased collagen type-I degradation. Furthermore, the finding that MMP-1 is an independent determinant of both PWV and AIx, not only in hypertension but also in healthy arteries, highlights the important role the extracellular matrix plays in mediating arterial stiffness. Furthermore, we have also seen significant associations between markers of collagen turnover and plasma triglycerides, LDL and HDL cholesterol, although the levels were not significantly different between the normotensive and hypertensive population. A previous study 24 has described a significant relationship between plasma lipoproteins and MMP-2, MMP-3 and MMP-9. These data suggest a possible link between atherosclerosis, collagen degradation and arterial stiffness.
The MMP/TIMP system plays an important role in the regulation of collagen turnover. This study has shown that not only is collagen synthesis increased in hypertension, but also that altered collagen turnover is strongly related to arterial stiffness. The fact that MMP-1 is related to PWV and AIx, in both healthy people and in hypertension, suggests that arterial stiffness is a product of an alteration in maintenance remodelling. However, in aging and hypertension, there is evidence of upregulation of these processes. Redmond et al. 25 have shown that MMP-1 expression is significantly upregulated in vascular smooth muscle cells exposed to pulsatile stress as opposed to static pressures. Also, as increased MMP-1 expression is associated with the phenotypic modulation of the vascular smooth muscle cell to a 'synthetic state' following injury to saphenous vein bypass grafts, this enzyme may be involved not only in collagen degradation, but may also contribute to intimal thickening. 26 However, whether the plasma levels reflect tissue activity of MMP-1 in hypertension or healthy subjects is uncertain.
When considering these results, it is important to realize that this study only concerns changes in collagen type-I degradation and is not reflective of total collagen degradation. There are a number of possible explanations for the relationship between collagen type-I degradation in relation to collagen type-I synthesis and increased arterial stiffness.
Collagen types show considerable diversity in their structure and function, and a change in the proportions of collagen subtypes can affect the mechanical properties of the vessel wall. Although collagen type-I comprises the majority of aortic collagen (70-75%), studies have shown that increases in collagen type-III and type-V occur during vascular stiffening in hypertension. In genetically hypertensive rats, large artery wall stiffness is affected not only by hypertension itself, but also by a higher density of collagen type-III, but not type-I fibres. 16 In addition, a study that examined changes in collagen subtypes in spontaneously hypertensive rats found decreased amounts of collagen type-I, accompanied by an increase in collagen type-V. 15 The alteration in the composition of collagen subtypes was accompanied by increased aortic stiffness. It has also been proposed that the loss of collagen from the vessel wall may be accompanied Arterial stiffness and collagen type-I degradation M McNulty et al by a greater loss of other vascular components leading to an overall increase in collagen concentration. 21 The inhibition of collagen degradation via MMPs after arterial injury and sustained blood flow changes resulted in diminished arterial remodelling, 27, 28 which suggests that collagen degradation may be involved in the arterial response to injury.
Although the absolute plasma PIP values obtained in this study are comparable with those obtained by others using the Takara ELISA kit 29, 30 and an immunoenzymatic method, 31 they are somewhat higher than values obtained in some recently published studies. 22, 23 These differences may be explained by variation in the PIP standard but do not detract from our findings of an association between levels and arterial stiffness. Furthermore, the role of the MMP/TIMP system may extend beyond the vasculature into the myocardium. Tayebjee et al. have shown a strong association between TIMP-1 levels and diastolic dysfunction in both hypertension and type II diabetes. Also, in hypertension, TIMP-1 levels are correlated with both left ventricular mass (LV mass) and LV mass index. 32, 33 In conclusion, alterations in collagen type-I independently determine not only large artery stiffness, but also play an important role in modulation of the smaller medium-sized vessels downstream, not only in patients with hypertension, but also in those with healthy arteries.
